NPD Measurements in PSC Patients
Cystic Fibrosis Transmembrane Conductance Regulator Function as Measured by Nasal Potential Difference Measurements in Patients With Primary Sclerosing Cholangitis
1 other identifier
observational
N/A
1 country
1
Brief Summary
Primary Sclerosing Cholangitis (PSC) is a chronic disorder of the liver causing jaundice and liver damage. When Cystic Fibrosis affects the liver, the damaged liver looks like the liver in PSC. This study is designed to answer the question whether isolated PSC may be a form of CF only in the liver
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2007
CompletedFirst Posted
Study publicly available on registry
May 22, 2007
CompletedOctober 31, 2007
October 1, 2007
May 21, 2007
October 30, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Age \> 10 years
- Patients diagnosed as Non-IBD PSC
- Patients diagnosed as IBD PSC
You may not qualify if:
- Age \< 10 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, 91240, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Wilschanski, Dr
Hadassah Medical Organization
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 21, 2007
First Posted
May 22, 2007
Last Updated
October 31, 2007
Record last verified: 2007-10